Roche Reports P-II Study (FENopta) Results of Fenebrutinib for the Treatment of Multiple Sclerosis
May 18, 2023
Roche Receives CHMP Recommendation for Approval of Columvi (glofitamab) to Treat Relapsed or Refractory Diffuse Large B-Cell Lymph...
April 26, 2023
Top 20 Drugs with US Patent Expiry in 2023 Based on Total Sales Value
March 29, 2023
Roche’s Columvi (glofitamab) Receives Health Canada Authorization for the Treatment of Adult Patients with Diffuse Large B-cell Ly...
March 27, 2023
Insights+: EMA Marketing Authorization of New Drugs in February 2023
March 23, 2023
Nirja Patel, Senior International Product Manager at Roche Shares her Views on the US FDA Approval of the PATHWAY anti-HER2 Test
March 7, 2023
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.